SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Chiron
An SI Board Since May 1996
Posts SubjectMarks Bans Symbol
1352 17 0 CHIR
Emcee:  Dahmane Dahmani Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
727 It is important to keep in mind that the clinical septic shock trials are a BayDavid Bogdanoff-5/21/1997
726 More disappointing news from CHIR re the Bayer septic shock trial for TNF antibGreg Spendjian-5/21/1997
725 Preliminary analysis of Bayer septic shock trial for TNF antibody shows disappoJohn Hunt-5/21/1997
724 Chiron analysts meeting at ASCO mmetng today in Denver. Focus was on cancer prTechperson-5/19/1997
723 Techperson mentioned in post 711 'DTaP panel meeting and Bayer clinical triC Bird-5/18/1997
722 I think this thread is getting too focussed on one drug worth $320M (MyotrophinBill Morel-5/18/1997
721 David, I think the term "imo" is where are positions differ, and we hWeirdPro Randy-5/17/1997
720 My post #113 was to clarify an otherwise accurate(imo) summary of the meeting fDavid Bogdanoff-5/16/1997
719 It is definitely agreed that further studies of myotrophin, via further phase IWeirdPro Randy-5/16/1997
718 WEST CHESTER, Pa., May 14 (Reuter) - Cephalon Inc <CEPH.O> said WednesdayLinda Kaplan-5/16/1997
717 Chip Roos, yes I have had that thought for a while now. Thought they were beinaknahow-5/16/1997
716 Do any of you guys get a bit nervous with all of the press releases that have cChip Roos-5/16/1997
715 The issue I addressed in my post was what was stated by the company in regardsDavid Bogdanoff-5/16/1997
714 David, of course CHIR/CEPH intend to market myotrophin for use in the treatmentWeirdPro Randy-5/16/1997
713 Nice summary but my understanding of what Chir/Ceph intend to do with MyotrophiDavid Bogdanoff-5/15/1997
712 Thanks for info. I did go and even saw MM there. DavidDavid Bogdanoff-5/15/1997
711 At the Chiron annual meeting today the head of clinical research gave a carefulTechperson-5/15/1997
710 Bill, I am not interested in flaming either. However, there is no other effectiVector1-5/15/1997
709 Bill, you write:<<Sorry, I don't get it...>> I do not wish to sWeirdPro Randy-5/15/1997
708 David: Meeting at Chiron Emeryville headquarters located at 1450 53rd St., EmTroll_29-5/15/1997
707 Its important to get the FDA rules straight. One rule is that a drug must be sDavid Bogdanoff-5/15/1997
706 Sorry, I don't get it... Not at all interested in starting up a flame war,Bill Ounce-5/15/1997
705 Thanks for your reply and your concern....Congress has also been putting presWeirdPro Randy-5/15/1997
704 Randy, thanks for the detail on the Myotrophin votes by the Advisory Panel. I Vector1-5/15/1997
703 Myotrophin was not rejected! Have been reading posts on this board since the adWeirdPro Randy-5/14/1997
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News